Search

Displaying results 6531 - 6540 of 6949 in total
  1. Drug

    AVI-4065

    go.drugbank.com/drugs/DB05620
    Investigational

    AVI-4065, a phosphorodiamidate Morpholino oligomer (PMO), is an investigational antisense HCV drug. It was developed by Sarepta Therapeutics, Inc. After phase II trials it was cancelled due to lack of potency.

  2. Drug

    ISIS 14803

    go.drugbank.com/drugs/DB05803
    Investigational

    ISIS 14803 is a 20-unit antisense phosphorothioate oligodeoxynucleotide that binds to hepatitis C virus (HCV) RNA at the translation initiation region of the internal ribosome entry site (IRES) and inhibits protein expression in cell cul...

  3. Drug

    AV-412

    go.drugbank.com/drugs/DB06021
    Investigational

    Categories: Receptor, ErbB-2, antagonists & inhibitors, Erb-b2 Receptor Tyrosine Kinases, antagonists & inhibitors
  4. Drug

    Apatorsen

    go.drugbank.com/drugs/DB06094
    Investigational

    Apatorsen is a second generation antisense drug which in preclinical experiments, inhibits production of Heat Shock Protein 27 (Hsp27) a cell survival protein found at elevated levels in many human cancers including prostate, lung, breas...

  5. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  6. Drug

    Refametinib

    go.drugbank.com/drugs/DB06309
    Investigational

  7. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

    Categories: Adenosine A1 Receptor Antagonists, Purinergic P1 Receptor Antagonists
  8. Drug

    MLN2222

    go.drugbank.com/drugs/DB06503
    Experimental

    MLN2222 is a novel, proprietary recombinant protein that blocks both the C3 and C5 convertases, which are essential components of the complement activation pathway.

  9. Drug

    Lerdelimumab

    go.drugbank.com/drugs/DB06557
    Experimental

  10. Drug

    AM365

    go.drugbank.com/drugs/DB06564
    Experimental

    Detiviciclovir (AM365) is an antiviral nucleoside analogue.